3-Brom-4-<2-methylen-butyryl>-phenoxyessigsaeure | 6467-28-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-Brom-4-<2-methylen-butyryl>-phenoxyessigsaeure
• 英文别名: 3-Brom-4-(2-methylen-butyryl)-phenoxyessigsaeure；[3-Bromo-4-(2-methylenebutyryl)phenoxy]acetic acid；2-[3-bromo-4-(2-methylidenebutanoyl)phenoxy]acetic acid
• CAS: 6467-28-3
• 化学式: C₁₃H₁₃BrO₄
• 分子量: 313.148
• InChiKey: PWUJFCZQHWZVEZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  18
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-Brom-4-<2-methylen-butyryl>-phenoxyessigsaeure 、 硫酸 在 crude product 、 溶剂黄146 作用下， 以yields substantially pure (1-oxo-2-ethyl-7-bromo-5-indanyloxy)acetic acid, m.p. 146°-148° C.的产率得到(7-Bromo-2-ethyl-1-oxo-indan-5-yloxy)-acetic acid
  参考文献：
  名称：

  [1-Oxo-2-halo(or hydrogen) indanyloxy]-alkanoic acid

  摘要：

  [1-氧代-2-卤代(或氢)吲哚氧(或硫)基]-脂肪酸产物及其盐、酯和酰胺衍生物，其中吲哚环上可能进一步取代2-5个核取代基团。[1-氧代-2-卤代吲哚氧(或硫)基]-脂肪酸可通过以下方法制备：(1)将[1-氧代吲哚氧(或硫)基]-脂肪酸卤化或(2)将卤素添加到[1-氧代茚氧(或硫)基]-脂肪酸中。[1-氧代吲哚氧(或硫)基]-脂肪酸可通过以下方法制备：(1)将(2-烷基亚酰基)-苯氧(或硫)基脂肪酸環化或(2)将羟基(或巯基)-2-烷基-1-茚酮醚化。[1-氧代-2-卤代(或氢)吲哚氧(或硫)基]-脂肪酸具有利尿和盐利尿作用。此外，其中一些化合物还能够维持体内尿酸浓度在治疗前的水平或引起尿酸浓度下降。

  公开号：

  US04070539A1
• 作为产物：
  描述：

  3-溴苯氧基乙酸 在 三氯化铝 、 potassium carbonate 作用下， 以 二硫化碳 为溶剂， 生成 3-Brom-4-<2-methylen-butyryl>-phenoxyessigsaeure
  参考文献：
  名称：

  The synthesis of α,β-unsaturated carbonyl derivatives with the ability to inhibit both glutathione S-transferase P1-1 activity and the proliferation of leukemia cells

  摘要：

  Ethacrynic acid (EA), an alpha,beta-unsaturated carbonyl compound, is a glutathione S-transferase P1-1 (GSTP1-1) inhibitor. Twenty-one novel EA derivatives have been synthesized. The effects of these compounds on GSTP1-1 activity and on the proliferation of human leukemia HL-60 cells have been determined. Compounds with a halogen substitution at the 3'-position of the aromatic ring have greater inhibitory effects on GSTP1-1 activity than those of compounds with a methyl substitution there. Compounds with substitutions at both the 2'- and 3'-positions of the aromatic ring have more antiproliferative ability than those with one substitution at 3'-position. Esterification of the carboxyl group appears to increase the antiproliferative ability. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.01.037

文献信息

• BE612755
  申请人：——

  公开号：——

  公开（公告）日：——
• (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
  申请人：MERCK &

  公开号：US03255241A1

  公开（公告）日：1966-06-07
• US4070539A
  申请人：——

  公开号：US4070539A

  公开（公告）日：1978-01-24
• The synthesis of α,β-unsaturated carbonyl derivatives with the ability to inhibit both glutathione S-transferase P1-1 activity and the proliferation of leukemia cells
  作者：Guisen Zhao、Chuan Liu、Rui Wang、Dandan Song、Xiaobing Wang、Hongxiang Lou、Yongkui Jing

  DOI：10.1016/j.bmc.2007.01.037

  日期：2007.4

  Ethacrynic acid (EA), an alpha,beta-unsaturated carbonyl compound, is a glutathione S-transferase P1-1 (GSTP1-1) inhibitor. Twenty-one novel EA derivatives have been synthesized. The effects of these compounds on GSTP1-1 activity and on the proliferation of human leukemia HL-60 cells have been determined. Compounds with a halogen substitution at the 3'-position of the aromatic ring have greater inhibitory effects on GSTP1-1 activity than those of compounds with a methyl substitution there. Compounds with substitutions at both the 2'- and 3'-positions of the aromatic ring have more antiproliferative ability than those with one substitution at 3'-position. Esterification of the carboxyl group appears to increase the antiproliferative ability. (c) 2007 Elsevier Ltd. All rights reserved.
• [1-Oxo-2-halo(or hydrogen) indanyloxy]-alkanoic acid
  申请人：Merck & Co., Inc.

  公开号：US04070539A1

  公开（公告）日：1978-01-24

  [1-Oxo-2-halo(or hydrogen)indanyloxy(or thio)]-alkanoic acid products and salts, esters and amide derivatives where the indanyl ring may be further substituted with from 2 to 5 nuclear substituents. The [1-oxo-2-haloindanyloxy-(or thio)]alkanoic acids are prepared (1) via the halogenation of a [1-oxoindanyloxy(or thio)]alkanoic acid or (2) via the addition of halogen to a [1-oxoindenyloxy(or thio)]-alkanoic acid. The [1-oxoindanyloxy(or thio)]alkanoic acids are prepared (1) via cyclialkylation of a (2-alkylideneacyl)-phenoxy(or thio)alkanoic acid or (2) via etherification of a hydroxy(or mercapto)-2-alkyl-1-indanone. The [1-oxo-2-halo(or hydrogen)indanyloxy(or thio)]alkanoic acids are diuretics and saluretics. In addition, some of these compounds are also able to maintain the uric acid concentration in the body at pretreatment level or to cause a decrease in uric acid concentration.

  [1-氧代-2-卤代(或氢)吲哚氧(或硫)基]-脂肪酸产物及其盐、酯和酰胺衍生物，其中吲哚环上可能进一步取代2-5个核取代基团。[1-氧代-2-卤代吲哚氧(或硫)基]-脂肪酸可通过以下方法制备：(1)将[1-氧代吲哚氧(或硫)基]-脂肪酸卤化或(2)将卤素添加到[1-氧代茚氧(或硫)基]-脂肪酸中。[1-氧代吲哚氧(或硫)基]-脂肪酸可通过以下方法制备：(1)将(2-烷基亚酰基)-苯氧(或硫)基脂肪酸環化或(2)将羟基(或巯基)-2-烷基-1-茚酮醚化。[1-氧代-2-卤代(或氢)吲哚氧(或硫)基]-脂肪酸具有利尿和盐利尿作用。此外，其中一些化合物还能够维持体内尿酸浓度在治疗前的水平或引起尿酸浓度下降。